Unknown

Dataset Information

0

Binding of sulphonated indigo derivatives to RepA-WH1 inhibits DNA-induced protein amyloidogenesis.


ABSTRACT: The quest for inducers and inhibitors of protein amyloidogenesis is of utmost interest, since they are key tools to understand the molecular bases of proteinopathies such as Alzheimer, Parkinson, Huntington and Creutzfeldt-Jakob diseases. It is also expected that such molecules could lead to valid therapeutic agents. In common with the mammalian prion protein (PrP), the N-terminal Winged-Helix (WH1) domain of the pPS10 plasmid replication protein (RepA) assembles in vitro into a variety of amyloid nanostructures upon binding to different specific dsDNA sequences. Here we show that di- (S2) and tetra-sulphonated (S4) derivatives of indigo stain dock at the DNA recognition interface in the RepA-WH1 dimer. They compete binding of RepA to its natural target dsDNA repeats, found at the repA operator and at the origin of replication of the plasmid. Calorimetry points to the existence of a major site, with micromolar affinity, for S4-indigo in RepA-WH1 dimers. As revealed by electron microscopy, in the presence of inducer dsDNA, both S2/S4 stains inhibit the assembly of RepA-WH1 into fibres. These results validate the concept that DNA can promote protein assembly into amyloids and reveal that the binding sites of effector molecules can be targeted to inhibit amyloidogenesis.

SUBMITTER: Gasset-Rosa F 

PROVIDER: S-EPMC2367726 | biostudies-literature | 2008 Apr

REPOSITORIES: biostudies-literature

altmetric image

Publications

Binding of sulphonated indigo derivatives to RepA-WH1 inhibits DNA-induced protein amyloidogenesis.

Gasset-Rosa Fátima F   Maté María Jesús MJ   Dávila-Fajardo Cristina C   Bravo Jerónimo J   Giraldo Rafael R  

Nucleic acids research 20080219 7


The quest for inducers and inhibitors of protein amyloidogenesis is of utmost interest, since they are key tools to understand the molecular bases of proteinopathies such as Alzheimer, Parkinson, Huntington and Creutzfeldt-Jakob diseases. It is also expected that such molecules could lead to valid therapeutic agents. In common with the mammalian prion protein (PrP), the N-terminal Winged-Helix (WH1) domain of the pPS10 plasmid replication protein (RepA) assembles in vitro into a variety of amylo  ...[more]

Similar Datasets

| S-EPMC4981189 | biostudies-literature
| S-EPMC3166502 | biostudies-literature
| S-EPMC5378768 | biostudies-literature
2017-06-13 | GSE69517 | GEO
| S-EPMC4794723 | biostudies-literature
| S-EPMC4589793 | biostudies-other
| S-EPMC7098005 | biostudies-literature
| S-EPMC2951245 | biostudies-literature
| S-EPMC5654847 | biostudies-literature
| S-EPMC1820612 | biostudies-literature